9 results
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
Pharmacology Cangrelor (Kengreal ... to the platelet P2Y12 ... pre-treated with an oral P2Y12 ... if the platelet P2Y12 ... stopped #Cangrelor #Kengreal
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Switching Between P2Y12 ... Inhibitors Oral P2Y12 ... Switching P2Y12 ... interactions between P2Y12 ... Prasugrel #P2Y12
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
combination with P2Y12 ... anticoagulation in a-fib P2Y12 ... - Inhibits the P2Y12
Clopidogrel (Plavix) and Clopidogrel Non-responders

Clopidogrel is an irreversible selective inhibitor of the platelet low-sensitivity adenosine diphosphate
diphosphate receptor: P2Y12
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Switching Between Oral P2Y12 ... CIRCULATIONAHA.117.031164 #P2Y12
Oral P2Y12 Inhibitor Pharmacology

 • Clopidogrel
 • Prasugrel
 • Ticagrelor

By Kyle Fischer, PharmD @Kfischer_10

#P2Y12 #Inhibitor #Pharmacology
Oral P2Y12 Inhibitor ... Kfischer_10 #P2Y12
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Antiplatelet Conversion - P2Y12 ... active site of the P2Y12 ... Antiplatelet #Conversion #P2Y12
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous
Adenosine Diphosphate P2Y12
Typical Therapeutic Applications of Penicillin G
Pneumococcal Pneumonia
 • Streptococcus pneumoniae is a major cause of bacterial
• A contagious venereal